Weekend Unlimited Inc. (“Weekend” or the “Company”) (CSE: POT, FSE: 0OS1, OTCQB:WKULF) is pleased to announce the Company’s flagship wknd! branded product line, consisting of Pre-rolls, Vape Pens & previously announced Cannagars is now in full production, preparing for launch in July.

“Our team has worked tirelessly to both design and produce a wknd! branded product line for launch in Washington, under the proviso that the product line must be replicable in other states systematically and sustainably,” said Weekend President and CEO, Chris Backus. “Our mandate on behalf of our shareholders is focused on getting product to market; we are making sure that in doing that we have products of the highest quality that will draw interest from retailers and generate excitement and loyalty from customers for the long-term.”


The Weekend team has worked to develop proprietary blends and formulations for the Company’s branded Pre-rolls, Cannagars and Vape pens – each offered in three sku’s named Bliss, Now and Escape – in order to ensure product quality and consistency for its customers. Benefitting from in depth retail consultation in Washington, the Company’s initial product launch includes the three products, each with three sku’s, in order to establish a strong retail presence and create momentum for further expansion.

Production Highlights

Pre-rolls for wknd!’s Bliss, Now and Escape branded products to use high quality strains for product consistency and will be packaged in custom high-5 collector tins
Cannagars for wknd!’s Bliss, Now and Escape branded products to use high quality strains for product consistency, serving as a high-end product differentiator for the cannabis connoisseur
Vape Pens for wknd!’s Bliss, Now and Escape branded products will feature a proprietary formulation for consistent taste and effect, replicable in other states in the future
“This market rollout serves multiple purposes, first, we have developed a branded product line to raise awareness and start building affinity for the wknd! flagship brand, second, the line has been developed with product attributes and formulations that can be consistently produced for quality assurance and replicated in other states, and third, and very importantly, with Washington State operating in the sector so efficiently in regard to both processes and relationships, we are designing and testing both our products and processes for long-term success here, and for expansion into additional states,” said Mr. Backus.

For further information, please contact:

Mr. Chris Backus, Interim President & CEO, Director
Telephone: 1(236) 317-2812 – Toll free 1(888) 556-9656
E-mail: IR@weekendunlimited.com

About Weekend Unlimited Inc.

Weekend Unlimited is a lifestyle-based recreational cannabis company. The Company is developing premium products designed to deliver life’s highs, anytime, anywhere. With a presence in both the U.S. and Canada – and a unique entertainment and education division (Weekend Live!), Weekend Unlimited is well-positioned to launch and scale the brands that will define recreational cannabis. Learn more at www.weekendunlimited.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management’s current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “predicts”, “intends”, “targets”, “aims”, “anticipates” or “believes” or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

Click here to connect with Weekend Unlimited (CSE:POT, FSE:0OS1) for an Investor Presentation.

Source: www.accesswire.com

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less